Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?

Overview of attention for article published in Frontiers in immunology, August 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 36,405 followers.

RT @FrontImmunol: Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?: Claire… https:/…

RT @FrontImmunol: Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?: Claire… https:/…

RT @FrontImmunol: Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?: Claire… https:/…

Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?: Claire… https://t.co/BsT66LK3B4

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.